BREAKING: ACIP launches sweeping Covid-19 vaccine review under Retsef Levi

Billions of Covid vaccine doses were rolled out on assurances they were safe and effective. Now, ACIP’s new Covid immunisation working group is asking the questions regulators never did.

Aug 21, 2025

∙ Paid

Cross-post from Maryanne Demasi, reports

Hello Subscribers! It has taken seven weeks of pushing against the bureaucracy to get to this point, but we are finally there. A huge step forward in the history of the ACIP, which is supposed to be an independent advisory organization for the CDC Director but has long been captured and controlled. You can find the newly approved scope of work for the ACIP Covid vaccine subcommittee here- https://www.cdc.gov/acip/our-work/index.html#heading-uuf6nwjsay - and you can read the HHS-approved statement and interview of the subcommittee chairperson below. We are making progress. I am sorry it is so slow (and frustrating for all concerned), but we now have the authorization to look deeply into the big questions. Hopefully, we will have some answers by the upcoming ACIP general meeting. -

Robert W Malone MD, MS

MIT professor Retsef Levi has been an outspoken voice on the CDC’s vaccine advisory committee (ACIP) since its dramatic overhaul in June.

He has pressed agency officials on uncomfortable questions, challenging the narrow surveillance windows used to track harms and insisting that delayed effects could not simply be ruled out.

He also raised concerns about the safety of RSV monoclonal antibodies after clinical trials showed a clear imbalance in infant deaths.

Now, Levi is no longer just a dissenter.

He has been appointed chair of the CDC’s new Covid-19 vaccine working group, and with today’s release of its Terms of Reference, the scale of his task has come into sharp focus.

Under the guidance of Levi and his colleagues, the ACIP working group now has a mandate unlike anything the committee has ever undertaken.

For the first time, federal advisers will investigate the unresolved issues that have dogged the vaccines since their rushed rollout in late 2020.

Subscribe to Maryanne Demasi, reports to continue reading

Visit the author’s Substack to subscribe and read more.